Multiple Endocrine Neoplasia Type 2a Associated with Cutaneous Lichen Amyloidosis
Overview
Affiliations
Purpose: To describe and characterize the association of hereditary cutaneous lichen amyloidosis with multiple endocrine neoplasia type 2a (MEN 2a).
Design: Survey of a family for two diseases.
Setting: Evaluation of patients at a clinical research center.
Patients: Nineteen family members with MEN 2a.
Measurements And Main Results: In this family cutaneous lichen amyloidosis presented as multiple infiltrated papules overlying a well-demarcated plaque in the scapular area of the back (right or left). Immunohistochemical studies showed amyloid that stained for keratin but not calcitonin. Three family members had the characteristic skin lesion and also carried the gene for MEN 2a; two additional members carried the gene for MEN 2a, but did not manifest the observable skin changes associated with lichen amyloidosis.
Conclusions: From the findings in this kindred and in another recently reported but unrelated family with an identical type of pruritic skin rash and MEN 2a, several conclusions can be drawn. First, the syndrome of cutaneous amyloidosis and MEN 2a is a clearly defined autosomal dominant hereditary syndrome. Second, the dermal amyloid appears to be caused by deposition of keratin-like peptides rather than by calcitonin-like peptides. Third, known families with hereditary lichen amyloidosis should be screened to determine the true frequency of this syndrome.
Stanescu L, Ghemigian A, Ciobica M, Nistor C, Ciuche A, Radu A Int J Mol Sci. 2024; 25(18).
PMID: 39337252 PMC: 11431960. DOI: 10.3390/ijms25189765.
Lanzaro F, De Biasio D, Cesaro F, Stampone E, Tartaglione I, Casale M J Clin Med. 2024; 13(18).
PMID: 39336996 PMC: 11432259. DOI: 10.3390/jcm13185510.
Genetic Testing for Successful Cancer Treatment.
Singh D, Daripelli S, Elamin Bushara M, Polevoy G, Prasanna M Cureus. 2024; 15(12):e49889.
PMID: 38179395 PMC: 10765765. DOI: 10.7759/cureus.49889.
A Case Report of Generalized Non-pruritic Lichen Amyloidosis.
Rousseau M, Valek S, Rashid R Cureus. 2023; 15(6):e39817.
PMID: 37397685 PMC: 10314308. DOI: 10.7759/cureus.39817.
Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes.
Nose V, Gill A, Teijeiro J, Perren A, Erickson L Endocr Pathol. 2022; 33(1):197-227.
PMID: 35285003 DOI: 10.1007/s12022-022-09705-5.